Cargando…
LECT2: A pleiotropic and promising hepatokine, from bench to bedside
LECT2 (leucocyte cell‐derived chemotaxin 2) is a 16‐kDa protein mainly produced by hepatocytes. It was first isolated in PHA‐activated human T‐cell leukaemia SKW‐3 cells and originally identified as a novel neutrophil chemotactic factor. However, many lines of studies suggested that LECT2 was a plei...
Autores principales: | Xie, Yuan, Fan, Kai‐Wei, Guan, Shi‐Xing, Hu, Yang, Gao, Yi, Zhou, Wei‐Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258709/ https://www.ncbi.nlm.nih.gov/pubmed/35656863 http://dx.doi.org/10.1111/jcmm.17407 |
Ejemplares similares
-
LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH
por: Takata, Noboru, et al.
Publicado: (2021) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Bench-to-bedside review: Fulfilling promises of the Human Genome Project
por: Chiche, Jean-Daniel, et al.
Publicado: (2002) -
Bench and Bedside
por: Schmidt, Christian
Publicado: (2002) -
Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside
por: Hu, Mengyuan, et al.
Publicado: (2023)